According to a study published in the Journal of Lancet’s EClinicalMedicine, covia patients who use thin blood may have a 50% lower risk of death and a 43% lower risk of hospitalization.
The study was conducted on 6,195 patients over the age of 18 who were diagnosed with Govt from March 4 to August 27, 2020 at 12 hospitals and 60 clinics in the United States.
Researchers at the University of Minnesota in the United States and the University of Basel in Switzerland studied the 90-day anticoagulant treatment and outpatient and mortality risk among outpatients prior to the diagnosis of Govit-19.
The researchers also assessed the relationship between anticoagulant treatment used to prevent blood clots and the risk of death in admitted patients.
The study found that patients with thinning blood before Govit-19 infection were 43% less likely to be hospitalized as adults and had more chronic medical conditions than their peers.
Whether used before the onset of Covid-19 disease or started when admitted to the hospital for treatment for a viral illness, blood thinners reduce deaths by almost half.
Overall, the researchers noted that Kovit patients admitted to the hospital benefit from hemorrhoids regardless of the type or dose of medication used.
Same Hossain, assistant professor of research at the University of Minnesota and lead author of the study, says:
“Medications prescribed to prevent hemorrhage in patients with anterior clots in the lungs or legs are blood thinners. They prevent blood clots in the brain from abnormal heart rhythms, such as secondary atrial fibrillation,” Same Hossain wrote in the journal.
Researchers are looking at whether blood thinners are standard in the treatment of these diseases, which is why Govt-19-related hospitals have been affected.
“We already know that too many hospitals pose a higher risk of death among their patients, so being hospitalized during the Govt-19 uprising could have a positive impact,” he added.
The researchers recommended that half of the patients have thin blood clots in their legs, lungs, abnormal heart rhythms or other causes.
They said overexposure to blood thinners already recommended would reduce the ill effects of Govit-19.
“Now at most centers around the world, there are protocols for thinning the blood when patients are first admitted to the hospital for Covit-19 – this is a proven key treatment option,” he said.
“Outside of Govit-19, thinner use of blood has been shown to be life-saving for people with coagulation conditions,” the scientist added.
The team is currently working with research groups in other parts of the world, such as Egypt, to see how low-investment health care systems and how hemorrhoids affect patients in different patient populations.